New Data on First-Line Psoriasis Drug ' Very Reassuring ' New Data on First-Line Psoriasis Drug ' Very Reassuring '
A higher cumulative dose of methotrexate taken did not increase the risk for liver fibrosis, but excess weight, metabolic syndrome, and diabetes did.Medscape News UK
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Dermatology Source Type: news
More News: Dermatology | Diabetes | Endocrinology | Liver | Metabolic Syndrome | Methotrexate | Psoriasis | Skin | Urology & Nephrology